is allulose a glp-1 agonist preliminary study of people with diabetes suggests that use of glucose-lowering drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 The Metabolic and Endocrine Effects

doi: 10.1007/s12288-015-0569-3

S2)):S157S163

When researchers administered Selank concurrently with phenazepam to human volunteers with anxiety spectrum disorders, the patients experienced all the expected benefits of phenazepamyet the drugs usual adverse effects, like memory loss and sleepiness, were significantly decreased by the addition of Selank [10]

GHK-Cu may support skin healing, improve coat quality, reduce joint inflammation, accelerate post-surgical recovery, and offer anti-aging effects

Importance of 503A Compounding and Clinical Oversight The 503A designation is critical for injectable GHK-Cu, particularly in a clinical context